Stock screenerAll disclosures →
EDGAR →
EDSA
Conviction 50HealthcareScan · Thu, Jun 25, 2026EDSA$7.45-6.29%
ResistanceSupportVol 14Vol MA14 250.82K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price7.45
Change-6.29%
Gap+2.89%
Rel volume0.24×
Avg volume242.06K
Avg $ vol1.52M
SMA 206.56
SMA 509.66
SMA 2004.41
Price vs 50-22.87%
Price vs 200+68.91%
MA stackmixed
50/200 cross—
Supertrenddown · 9.31
RSI (14)48
MACD hist0.35
MACD crossbull · 5d
Stoch %K / %D79 / 91
ADX (14)24
+DI / −DI20 / 21
RSI divergence—
MACD divergenceBullish
ATR %+16.29%
ADR %14.94%
52w high18.28
52w low0.8000
From 52w high-59.23%
Above 52w low+831.25%
New 52w highNo
SqueezeOff
Bollinger width54.87%
%B0.75
Donchian pos79.07%
Donchian high8.22
Donchian low4.56
AVWAP (52w high)10.70
vs AVWAP high-30.36%
AVWAP (52w low)3.89
vs AVWAP low+91.48%
OBV trendFlat
Chaikin MF (20)-0.19
Today vs 20d0.24×
Avg vol (14d)250.82K
Avg vol (20d)242.06K
Avg $ vol (20d)1.52M
Market cap66.25M
RS 3m (vs SPY)+0.99%
RS 6m (vs SPY)+429.43%
RS line new highNo
Trend template6/8
Technical rank69.9
1 week+8.28%
1 month-23.20%
3 months+13.39%
6 months+410.27%
1 year+272.50%
YTD+396.67%
P/E-9.22
P/B6.50
P/S—
P/FCF-9.05
EPS-0.5700
Div yield—
ROE-70.47%
ROA-58.02%
Debt/Eq—
Current4.76
EV/EBITDA-7.22
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-16.46%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value56.25M
Revenue0
Net income-4.22M
Gross profit—
Free cash flow-7.32M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out8.89M
Employees17
ListedWed, Jun 9, 2010
Free float3.6M
Float %51.1%
Short interest238.71K
Days to cover0.6d
Short volume43.3%
Squeeze score18 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeC
Conviction50 / 100
Pattern quality—
Tech rank69.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance19.07
Support5.53
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in EDSA
No recent disclosed trades by Congress in EDSA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in EDSA · 6 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Nijhawan Pardeep Chief Executive Officer · Common Shares · 2026-06-01 | Other | — | — | 2026-06-01 | 2026-06-01 |
Nijhawan Pardeep Chief Executive Officer · Common Shares · 2026-06-01 | Grant | 1.67K | $0 | 2026-06-01 | 2026-06-01 |
Marshall Patrick Director · Common Shares · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-29 |
Sistilli Carlo Director · Common Shares · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-29 |
Sistilli Carlo Director · Common Shares · 2026-05-27 | Grant | 19K | $0 | 2026-05-27 | 2026-05-29 |
Marshall Patrick Director · Common Shares · 2026-05-27 | Grant | 19K | $0 | 2026-05-27 | 2026-05-29 |
Brooks Michael J President · Common Shares · 2026-05-27 | Grant | 64.61K | $0 | 2026-05-27 | 2026-05-29 |
Nijhawan Pardeep Chief Executive Officer · Common Shares · 2026-05-27 | Grant | 96.91K | $0 | 2026-05-27 | 2026-05-29 |
Chypyha Joan Director · Common Shares · 2026-05-27 | Grant | 19K | $0 | 2026-05-27 | 2026-05-29 |
Nijhawan Pardeep Chief Executive Officer · Common Shares · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-29 |
SEC filings
EDGAR filings in EDSA · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.